AGTC News and Press, Applied Genetic Technologies Corporation From 01/23/20

Investors are underwhelmed with Applied Genetic Technologies' (NASDAQ: AGTC ) announcement of "encouraging six-month data" from 22 patients participating in Phase 1/2 studies of its AAV gene therapy in patients with achromatopsia (color blindness) due to mutations in the ACHM CNGB3 or A...

–Encouraging preliminary signs of biologic activity and a favorable safety profile are outcomes that are clinically relevant to patients – Enrollment ongoing in additional dose groups, which will include pediatric patients; interim data from these additional dose gro...

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Jan. 22, 2020 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announce...

Management and External Thought Leaders to Discuss Data from XLRP and ACHM Phase 1/2 Clinical Trials Webcast Scheduled from 7:30 am – 12:00 pm ET GAINESVILLE, Fla. and CAMBRIDGE, Mass., Jan. 21, 2020 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC)...

Gainers:  Sorrento Therapeutics (NASDAQ: SRNE )  +38% . More news on: Sorrento Therapeutics, Inc., Ultragenyx Pharmaceutical Inc., Venus Concept Inc., Stocks on the move, Read more ...

Penny stocks are some of the most unique in the market. The biggest reason has to do with the ability to move unassociated with the direction of the stock market. Now, this isn’t always the case. But there’s a good chance that even if the broad stock market is tanking, there are ...

Applied Genetic Technologies Corporation ( AGTC ) closed higher on Thursday by 123% to $9.27 per share, after it had announced a positive update from its phase 1/2 study using its gene therapy to treat patients with x-linked retinitis pigmentosa. The main thing is that this newly reported da...

Portola Pharmaceuticals (NASDAQ: PTLA )  -41%  on preliminary Q4 and FY 2019 results. More news on: Portola Pharmaceuticals, Inc., cbdMD, Inc., Naked Brand Group Limited, Stocks on the move, Read more ...

Applied Genetic Technologies Corporation (AGTC) XLRP Six-month Dose Expansion Data Conference Call and Webcast January 09, 2020 8:00 AM ET Company Participants Susan Washer – President and Chief Executive Officer Matt Feinsod – Executive Vice President of Global Strat...

The following slide deck was published by Applied Genetic Technologies Corporation in conjunction with this Read more ...